PROVENZANO, Michele
 Distribuzione geografica
Continente #
AS - Asia 4.592
NA - Nord America 2.049
SA - Sud America 1.205
EU - Europa 793
AF - Africa 184
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.831
Nazione #
SG - Singapore 2.037
US - Stati Uniti d'America 1.875
BR - Brasile 860
VN - Vietnam 778
CN - Cina 718
HK - Hong Kong 337
FR - Francia 190
KR - Corea 139
IT - Italia 135
AR - Argentina 125
DE - Germania 98
BD - Bangladesh 93
IQ - Iraq 89
IN - India 87
MX - Messico 80
FI - Finlandia 67
GB - Regno Unito 55
ZA - Sudafrica 55
RU - Federazione Russa 54
EC - Ecuador 49
CO - Colombia 48
CA - Canada 43
PK - Pakistan 42
ID - Indonesia 41
VE - Venezuela 39
UZ - Uzbekistan 30
NL - Olanda 29
UA - Ucraina 28
MA - Marocco 24
PY - Paraguay 24
TR - Turchia 24
CL - Cile 22
PH - Filippine 22
SA - Arabia Saudita 22
KE - Kenya 21
PL - Polonia 20
TN - Tunisia 17
UY - Uruguay 16
AZ - Azerbaigian 15
EG - Egitto 15
IE - Irlanda 14
DZ - Algeria 13
ET - Etiopia 13
JO - Giordania 12
NP - Nepal 12
PE - Perù 12
ES - Italia 11
MY - Malesia 11
SE - Svezia 11
CR - Costa Rica 10
DO - Repubblica Dominicana 10
MT - Malta 10
PA - Panama 10
AT - Austria 9
JP - Giappone 9
KZ - Kazakistan 9
BO - Bolivia 8
IL - Israele 8
KG - Kirghizistan 8
LB - Libano 7
PS - Palestinian Territory 7
SN - Senegal 7
CH - Svizzera 6
HN - Honduras 6
JM - Giamaica 6
LT - Lituania 6
AE - Emirati Arabi Uniti 5
BA - Bosnia-Erzegovina 5
OM - Oman 5
BE - Belgio 4
EE - Estonia 4
KH - Cambogia 4
LK - Sri Lanka 4
RS - Serbia 4
SK - Slovacchia (Repubblica Slovacca) 4
AM - Armenia 3
AO - Angola 3
AU - Australia 3
BG - Bulgaria 3
BY - Bielorussia 3
HU - Ungheria 3
MD - Moldavia 3
PT - Portogallo 3
RO - Romania 3
SY - Repubblica araba siriana 3
AL - Albania 2
BZ - Belize 2
CZ - Repubblica Ceca 2
GE - Georgia 2
HR - Croazia 2
IR - Iran 2
KW - Kuwait 2
LY - Libia 2
ML - Mali 2
NR - Nauru 2
TG - Togo 2
TT - Trinidad e Tobago 2
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
Totale 8.804
Città #
Singapore 816
San Jose 561
Boardman 344
Hong Kong 335
Ho Chi Minh City 292
Ashburn 285
Hefei 236
Hanoi 162
Beijing 159
Lauterbourg 141
Seoul 139
Dallas 118
São Paulo 80
Helsinki 50
New York 40
Los Angeles 36
Munich 36
Mexico City 35
Baghdad 33
Da Nang 33
Haiphong 28
Santa Clara 28
The Dalles 25
Phoenix 24
Rio de Janeiro 24
Tashkent 24
Guayaquil 23
Tianjin 23
Biên Hòa 22
Johannesburg 19
Belo Horizonte 18
Falkenstein 18
Guangzhou 18
Amsterdam 17
Curitiba 17
Dhaka 17
Warsaw 17
Atlanta 16
Frankfurt am Main 16
Milan 16
Shanghai 16
Brasília 15
Brooklyn 15
Medellín 15
Dublin 14
Hải Dương 14
Nairobi 14
Orem 14
Rome 14
Addis Ababa 13
Baku 13
Chennai 13
Council Bluffs 13
Montreal 13
Toronto 13
Asunción 12
Chicago 12
Montevideo 12
Ribeirão Preto 12
Santiago 12
Thái Bình 12
Campinas 11
Can Tho 11
Cape Town 11
Denver 11
Erbil 11
Guarulhos 11
London 11
Nuremberg 11
Phủ Lý 11
Birkirkara 10
Boston 10
Ninh Bình 10
Quito 10
Riyadh 10
Amman 9
Bogotá 9
Fortaleza 9
Hyderabad 9
Jakarta 9
Karachi 9
Stockholm 9
Thái Nguyên 9
Bắc Ninh 8
Chandler 8
Hillsboro 8
Tunis 8
Turku 8
Bishkek 7
Dakar 7
Durban 7
Formosa 7
Ha Long 7
Jeddah 7
Jiaxing 7
Manchester 7
Mumbai 7
Paris 7
Rende 7
San José 7
Totale 4.967
Nome #
[Semaglutide in Chronic Kidney Disease: Great Enthusiasm. But How Does It Work?] 113
Artificial intelligence in chronic kidney diseases: methodology and potential applications 111
Sex difference in cardiovascular risk in patients with chronic kidney disease: pooled analysis of four cohort studies 108
Assessment of androgen receptor, IGF-IR and insulin receptor expression in male patients with severe peripheral artery disease 104
Precision subclassification of type 2 diabetes: a systematic review 91
I disegni di studio utilizzati nella ricerca epidemiologica delle malattie croniche 90
Albuminuria-Lowering Effect of Dapagliflozin, Eplerenone, and Their Combination in Patients with Chronic Kidney Disease: A Randomized Crossover Clinical Trial 89
Association between Inguinal Hernia and Arterial Disease: A Preliminary Report 89
15-year-change of phenotype and prognosis in non-dialysis CKD patients referred to a nephrology clinic 88
[Peritoneal dialysis catheter infection with abscess of the abdominal wall in a ADPKD patient] 86
Acute Kidney Injury and Blood Purification Techniques in Severe COVID-19 Patients 86
Clinical and patient-reported trajectories at end-of-life in older patients with advanced CKD 85
Predicting Kidney Failure, Cardiovascular Disease and Death in Advanced CKD Patients 85
The impact of gender on the risk of cardiovascular events in older adults with advanced chronic kidney disease 84
Proteomic Changes Induced by the Immunosuppressant Everolimus in Human Podocytes 84
Precision gestational diabetes treatment: a systematic review and meta-analyses 83
Secular Trend in GFR Decline in Non-Dialysis CKD Based on Observational Data From Standard of Care Arms of Trials 83
[Ultrasonography in chronic lithium nephropathy: a case report] 82
Refining the diagnosis of gestational diabetes mellitus: a systematic review and meta-analysis 81
[Finerenone for the treatment of patients with chronic kidney disease] 81
[Epidemiology and prognosis of chronic kidney disease in Italy] 79
Associations between depressive symptoms and disease progression in older patients with chronic kidney disease: results of the EQUAL study 79
Precision stratification of prognostic risk factors associated with outcomes in gestational diabetes mellitus: a systematic review 77
Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review 77
Atherosclerotic-nephropathy: an updated narrative review 76
Antiproteinuric effect of paricalcitol in kidney transplant recipients with severe proteinuria: a prospective cohort study 76
Association between Chronic Kidney Disease-Mineral and Bone Disorder Biomarkers and Symptom Burden in Older Patients with Advanced Chronic Kidney Disease: Results from the EQUAL Study 75
[Role of Ambulatory Blood Pressure Monitoring (ABPM) in chronic kidney patients: a review] 75
The relationship between uremic toxins and symptoms in older men and women with advanced chronic kidney disease 75
Effective interventions in preventing gestational diabetes mellitus: A systematic review and meta-analysis 75
Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine 74
Area Deprivation and Risk of Death and CKD Progression: Long-Term Cohort Study in Patients under Unrestricted Nephrology Care 74
The Kidney Protective Effects of the Sodium–Glucose Cotransporter-2 Inhibitor, Dapagliflozin, Are Present in Patients With CKD Treated With Mineralocorticoid Receptor Antagonists 73
Th17-Gene Expression Profile in Patients with Chronic Venous Disease and Venous Ulcers: Genetic Modulations and Preliminary Clinical Evidence 72
The use of precision diagnostics for monogenic diabetes: a systematic review and expert opinion 71
[Temporal variation of Chronic Kidney Disease's epidemiology] 71
The use of the Amplatzer Vascular Plug in the prevention of endoleaks during abdominal endovascular aneurysm repair: A systematic literature review on current applications 70
The Impact of Chronic Kidney Disease on Peripheral Artery Disease and Peripheral Revascularization 69
An open-label, randomized, placebo-controlled study on the effectiveness of a novel probiotics administration protocol (ProbiotiCKD) in patients with mild renal insufficiency (stage 3a of CKD) 69
New-onset anemia and associated risk of ESKD and death in non-dialysis CKD patients: a multicohort observational study 68
Hyperkalemia in CKD: an overview of available therapeutic strategies 68
Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review 68
Omics in chronic kidney disease: Focus on prognosis and prediction 68
Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic review 67
Exploring the Level of Post Traumatic Growth in Kidney Transplant Recipients via Network Analysis 67
The Shaggy Aorta Syndrome: an updated review 67
Generalizability of DAPA-CKD trial to the real-world setting of outpatient CKD clinics in Italy 66
Up-Date on Diabetic Nephropathy 66
Cathepsin-K is a potential cardiovascular risk biomarker in prevalent hemodialysis patients 66
Hypoxia-inducible factor stabilizers in end stage kidney disease: “can the promise be kept?” 65
Estimated glomerular filtration rate in observational and interventional studies in chronic kidney disease 65
Role of a dual glucose-dependent insulinotropic peptide (GIP)/glucagon-like peptide-1 receptor agonist (twincretin) in glycemic control: From pathophysiology to treatment 65
Predictive effect of salt intake on patient and kidney survival in non-dialysis CKD: competing risk analysis in older versus younger patients under nephrology care 64
Unraveling Cardiovascular Risk in Renal Patients: A New Take on Old Tale 63
Efficacy and Safety of Jotec E-Ventus BX Stent Graft for Iliac Branch Device Procedure: A Retrospective Clinical Study 62
P1422CATHEPSIN-K IS A POWERFUL DIAGNOSTIC BIOMARKER IN PARATHYROIDECTOMIZED DIALYSIS PATIENTS 62
Impact of individual and environmental factors on dietary or lifestyle interventions to prevent type 2 diabetes development: a systematic review 61
Participant characteristics in the prevention of gestational diabetes as evidence for precision medicine: a systematic review and meta-analysis 61
Fabry disease: a rare disorder calling for personalized medicine. 61
Impact of Baseline Clinical Variables on SGLT2i’s Antiproteinuric Effect in Diabetic Kidney Disease 61
Aortic Aneurysms, Chronic Kidney Disease and Metalloproteinases 61
Carotid Endarterectomy versus Carotid Artery Stenting With Double-Layer Micromesh Carotid Stent: Contemporary Results of a Single-Center Retrospective Study 60
Precision Nephrology in Patients with Diabetes and Chronic Kidney Disease 60
Efficacy and safety of switching from Eculizumab to Ravulizumab for the maintenance of aHUS remission after kidney transplant: a preliminary experience 59
Clinical and Pathological Correlations in Chronic Venous Disease 59
Chronic Hyperkaliemia in Chronic Kidney Disease: An Old Concern with New Answers 58
The Use of Demoralization Scale in Italian Kidney Transplant Recipients 58
Contribution of Predictive and Prognostic Biomarkers to Clinical Research on Chronic Kidney Disease 58
Precision prognostics for cardiovascular disease in Type 2 diabetes: a systematic review and meta-analysis 58
Coronary Artery Disease in Patients Undergoing Hemodialysis: A Problem that Sounds the Alarm 57
Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis 57
Role of Estimated Glomerular Filtration Rate in Clinical Research: The Never-Ending Matter 57
Ultrasonography of quadriceps femoris muscle and subcutaneous fat tissue and body composition by BIVA in chronic dialysis patients 57
Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies 56
Improving Kidney Disease Care: One Giant Leap for Nephrology 56
Bone Mineral Density Changes in Long-Term Kidney Transplant Recipients: A Real-Life Cohort Study of Native Vitamin D Supplementation 56
RAAS Inhibitor Prescription and Hyperkalemia Event in Patients With Chronic Kidney Disease: A Single-Center Retrospective Study 56
P1417ALTERED CATHEPSIN-K LEVELS REFLECT SEVERITY OF MINERAL BONE DISEASE AND INFLAMMATION IN CHRONIC HEMODIALYSIS PATIENTS 55
Diet and Physical Activity in Adult Dominant Polycystic Kidney Disease: A Review of the Literature 55
Risk of end-stage kidney disease in kidney transplant recipients versus patients with native chronic kidney disease: multicentre unmatched and propensity-score matched analyses 55
Increased circulating Cathepsin-K levels reflect PTH control in chronic hemodialysis patients 54
Role of serum complement C3 and C4 on kidney outcomes in IgA nephropathy 54
Impact of random variation in albuminuria and estimated glomerular filtration rate on patient enrolment and duration of clinical trials in nephrology 54
“Eculizumab First” in the Management of Posttransplant Thrombotic Microangiopathy 54
The effects of somatostatin analogues on liver volume and quality of life in polycystic liver disease: a meta-analysis of randomized controlled trials 54
Workplace Violence towards Healthcare Workers: An Italian Cross-Sectional Survey 54
La gestione dell'iperpotassiemia: nefrologo e cardiologo a confronto [Management of hyperkalemia in Nephrology and Cardiology clinics: reality and perspectives] 53
New paradigm for the management of cardio-nephro-metabolic syndrome: multidisciplinary approach and role of telemedicine 52
Prognostic role of LDL cholesterol in non-dialysis chronic kidney disease: Multicenter prospective study in Italy 52
Remote patient monitoring in dialysis patients: The "change of pace" for home dialysis | [Monitoraggio da remoto del paziente in dialisi: Il cambio di passo per la dialisi domiciliare?] 52
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics 51
Genotype-stratified treatment for monogenic insulin resistance: a systematic review 51
Glomerular and tubular effects of dapagliflozin, eplerenone and their combination in patients with chronic kidney disease: A post‐hoc analysis of the ROTATE‐3 study 51
Statins in patients with chronic kidney disease: new evidence 50
Blood Pressure Variability, Mortality, and Cardiovascular Outcomes in CKD Patients 49
Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria 49
Prognosis and determinants of serum PTH changes over time in 1-5 CKD stage patients followed in tertiary care 49
Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio as Biomarkers for Cardiovascular Surgery Procedures: A Literature Review 49
Utility of Blood Flow/Resistance Index Ratio (Q x) as a Marker of Stenosis and Future Thrombotic Events in Native Arteriovenous Fistulas 48
Short-term blood pressure variability in nondialysis chronic kidney disease patients: correlates and prognostic role on the progression of renal disease 48
Totale 6.747
Categoria #
all - tutte 46.861
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.861


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20224 0 0 0 0 0 0 0 1 0 0 1 2
2022/202321 4 2 0 1 2 2 0 2 6 0 1 1
2023/2024268 1 0 0 1 2 2 1 1 1 1 141 117
2024/20252.483 404 364 91 87 33 111 34 82 369 94 214 600
2025/20266.398 970 345 326 627 1.249 500 989 408 408 576 0 0
Totale 9.174